| 0 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
4 |
0.0004 |
| 1 |
Cephalosporin Antibacterial [EPC] |
1 |
0.0001 |
| 2 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2 |
0.0001 |
| 3 |
Melatonin Receptor Agonist [EPC] |
1 |
0.0001 |
| 4 |
Prostaglandin E1 Analog [EPC] |
1 |
0.0001 |
| 5 |
Orexin Receptor Antagonist [EPC] |
1 |
0.0001 |
| 6 |
Carbonic Anhydrase Inhibitor [EPC] |
1 |
0.0000 |
| 7 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
2 |
0.0000 |
| 8 |
Nitrate Vasodilator [EPC] |
2 |
0.0000 |
| 9 |
CTLA-4-directed Blocking Antibody [EPC] |
1 |
0.0000 |
| 10 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 11 |
Retinoid [EPC] |
5 |
0.0000 |
| 12 |
Macrolide Antimicrobial [EPC] |
1 |
0.0000 |
| 13 |
Central alpha-2 Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 14 |
Parathyroid Hormone Analog [EPC] |
2 |
0.0000 |
| 15 |
Methylxanthine [EPC] |
1 |
0.0000 |
| 16 |
Histamine-2 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 17 |
Expectorant [EPC] |
3 |
0.0000 |
| 18 |
Tetracycline-class Drug [EPC] |
1 |
0.0000 |
| 19 |
Androgen Receptor Inhibitor [EPC] |
1 |
0.0000 |
| 20 |
Xanthine Oxidase Inhibitor [EPC] |
2 |
0.0000 |
| 21 |
Central Nervous System Stimulant [EPC] |
1 |
0.0000 |
| 22 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1 |
0.0000 |
| 23 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
1 |
0.0000 |
| 24 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 25 |
Acetylcholine Release Inhibitor [EPC] |
1 |
0.0000 |
| 26 |
Dihydropyridine Calcium Channel Blocker [EPC] |
3 |
0.0000 |
| 27 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 28 |
GLP-1 Receptor Agonist [EPC] |
4 |
0.0000 |
| 29 |
Insulin Analog [EPC] |
4 |
0.0000 |
| 30 |
Aromatase Inhibitor [EPC] |
1 |
0.0000 |
| 31 |
Sulfonylurea [EPC] |
1 |
0.0000 |
| 32 |
Fluoroquinolone Antibacterial [EPC] |
1 |
0.0000 |
| 33 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
1 |
0.0000 |
| 34 |
Opioid Agonist [EPC] |
2 |
0.0000 |
| 35 |
Platinum-based Drug [EPC] |
2 |
0.0000 |
| 36 |
Nucleoside Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 37 |
Factor Xa Inhibitor [EPC] |
2 |
0.0000 |
| 38 |
Interleukin-6 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 39 |
Selective T Cell Costimulation Modulator [EPC] |
1 |
0.0000 |
| 40 |
Calcium [EPC] |
1 |
0.0000 |
| 41 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 42 |
Angiotensin 2 Receptor Blocker [EPC] |
2 |
0.0000 |
| 43 |
Platelet Aggregation Inhibitor [EPC] |
3 |
0.0000 |
| 44 |
Proton Pump Inhibitor [EPC] |
3 |
0.0000 |
| 45 |
Thiazide Diuretic [EPC] |
1 |
0.0000 |
| 46 |
Corticosteroid [EPC] |
6 |
0.0000 |
| 47 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 48 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 49 |
Atypical Antipsychotic [EPC] |
2 |
0.0000 |
| 50 |
Loop Diuretic [EPC] |
2 |
0.0000 |
| 51 |
Tumor Necrosis Factor Blocker [EPC] |
4 |
0.0000 |
| 52 |
Thalidomide Analog [EPC] |
2 |
0.0000 |
| 53 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
5 |
0.0000 |
| 54 |
Osmotic Laxative [EPC] |
1 |
0.0000 |
| 55 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 56 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 57 |
Folate Analog Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 58 |
Benzodiazepine [EPC] |
1 |
0.0000 |